Clinical Trials on The Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipi in Switzerland
Total 0 results
Nothing found
Sponsors and Collaborators
- Lynn Sage Breast Cancer Research Foundation
- JDP Therapeutics, Inc.
- FRM
- Plant & food Research Ltd
- Penn State Hershey Children's Hospital
- University of Tulsa
- Prairie Vascular Research Inc.
- Tzu-Yun Wang
- SC Medica
- University of Tennessee Cancer Institute
- Université d'Évry
- Nigar Dursun
- Institut de Cancérologie de Lorraine
- Nando and Elsa Peretti Foundation
- Irise International
- KWJ Engineering
- Home care nursing in the Municipality of Næstved
- Special Hospital for Orthopedics Biograd na Moru
- University Hsopital of Magdeburg
- Ellume Pty Ltd
- View Full List
Medical Conditions
- Malignant Lymphomas High Grade
- Biliary Duct Stricture
- Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL
- Intrusive Memories of Trauma, Symptom of Post Traumatic Stress Disorder (Criterion B1)
- ETRE With BISC (Brief Intense Stair Climbing)
- Drug-Drug Interactions
- Peripheral T-cell Lymphoma, Nonspecific
- Low Grade Ovarian Endometrioid Adenocarcinoma
- Postsurgical Hypothyroidism
- Toilet Training
- Nursing Personnel
- MIC
- PLATELET AGGREGATION
- Stage IIIC Fallopian Tube Cancer AJCC v8
- Determine Sensitivity of Skin to Cetaphil Daily Advance Ultra Hydrating Lotion
- Peritraumatic Amnesia
- Bone Quality Assessment
- Colon or Upper Rectum Adenocarcinoma
- Response Evaluation Criteria in Solid Tumors
- Periodontal Recessions
- View Full List
Drug Interventions
- 68Ga-HX01
- Thalidomide
- Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem
- Rifapentine and Isoniazid weekly for 12 weeks
- Abiraterone acetate
- IPCI (CDDP+5FU)
- Bortezomib
- Vildagliptin
- MRG003
- Bevacizumab
- Dronabinol
- Rotigotine PR 2.1.4
- CFI-402257
- Exemestane
- Asacol 400 mg
- Korlym (mifepristone)
- Azathioprine (AZA)
- Eribulin
- Teysuno (S1) in combination with epirubicin and oxaliplatin
- ZD6474 (vandetanib)
- View Full List
CROs by country
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Germany
- Contract Research Organizations in Ghana
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Saudi Arabia
- Contract Research Organizations in Turkmenistan
- Contract Research Organizations in United Kingdom
- Contract Research Organizations in Zambia
- Contract Research Organizations in Zimbabwe
- CRO list by country